A non-significant decrease in blood pressure, IR-iAUC, cholesterol, and triglycerides and a significantly reduced level of CRP were found in individuals at risk of T2D after a four-week intervention in those consuming the FRDF-based beverage when compared to those receiving general health advice. This evidence concerns the gene CRP and type 2 diabetes mellitus.